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ABSTRACT: 
Resveratrol, is a polyphenol that can be extracted from grapes and red wine, possess potential 
anti-inflammatory effects, which would result in the reduction of cytokine production, the 
alteration of the expression of adhesion molecule molecules, and the inhibition of neutrophil 
function. Resveratrol might also act as an antioxidant, anti-aging, and control of cell cycle 
and  apoptosis.  Resveratrol  has  been  shown  to  have  protective  effects  for  patients  in 
shock-like states. Such protective phenomenon is reported to be implicated in a variety of 
intracellular  signaling  pathways  including  the  regulation  of  the  mitogen-activated  protein 
kinases (MAPK)/ hemeoxygenase-1 (HO-1) pathway, activates estrogen receptor (ER), and 
the mediation of pro-inflammatory cytokines, reactive oxygen species (ROS) formation and 
reactive.  Moreover,  through  anti-inflammatory  effects  and  antioxidant  properties,  the 
resveratrol is believed to maintain organ function following trauma-hemorrhage.   
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INTRODUCTION: 
Resveratrol is a naturally occurring plant antibiotic known as phytoalexins, found in many Functional Foods in Health and Disease 2012, 2(10):351-368                                                  Page 352 of 368 
 
plants, nuts, and fruits, and is abundant in grapes and red wine [1,2]. Several recent reports 
have  shown  the  protective  effects  of  resveratrol  in  different  pathological  models  and 
experimental conditions [3-7]. Many clinical researchers also indicate the beneficial effects of 
resveratrol  in  various  human diseases [8-13]. A  growing body of evidence indicates that 
resveratrol may play potential therapeutic roles in human health by its various beneficial 
biological  effects,  e.g.,  anti-inflammation,  anti-aging,  antioxidant,  anti-diabetes,  and 
apoptosis  [10,14-17].  A  number  of  target  molecules  mediating  the  above  mentioned 
protective effects of resveratrol have been identified, including the AMP-activated protein 
kinase (AMPK), the Akt kinase, the estrogen receptors (ER), the adenosine receptor, the 
cyclooxygenase-1 (COX-1), the histone/protein deacetylase sirtuin 1 (SIRT1), the nuclear 
factor-E2- related factor-2 (Nfr2), and Nuclear Factor-Kappa B (NF-kB) [1,18]. A variety of 
laboratory and clinical studies also indicate that resveratrol may lead to organ and tissue 
protective effects against various injuries [20-26]. Ischemic/reperfusion injury induces free 
radical formation and inflammation within hours and results in the excessive production of 
pro-inflammatory mediators that play a significant role in the development of multiple organ 
dysfunctions under those conditions [27,28]. Specifically, resveratrol has been suggested as a 
therapeutic  agent  to  treat  shock-like  and  ischemic  states  due  to  its  anti-oxidative  and 
anti-inflammatory activities [29-35]. In this review, we summarize the protective pathways of 
resveratrol with emphasis on maintenance of organ function following trauma-hemorrhage 
(T-H) (Table 1).   
 
The protective effect of resveratrol on lung following T-H 
Trauma-hemorrhage results in excessive production of pro-inflammatory mediators, such as 
cytokines  and  chemokines.  The  enhanced  secretion  of  pro-inflammatory  cytokines  is  an 
important factor in the initiation and perpetuation of organ injury [29,36,37]. These cytokines 
recruit other immune cells including neutrophils, thereby increasing leukocyte trafficking and 
organ injury [38-40]. Neutrophils can release mediators which diffuse across the endothelium 
and injure parenchymal cells [38,40]. In addition, neutrophils can leave the microcirculation 
and migrate to matrix proteins or other cells [29,38,40]. Studies have shown that neutrophils 
are  activated  following  T-H  [39,40]  and  that  lung  injury  is  associated  with  an  increased 
neutrophil  accumulation  in  the  lung  after  T-H  [29,41].  Studies  have  been  reported  that 
reduction of neutrophil accumulation is shown to play a protective role in organ damage after 
T-H [27,29,36]. The activated neutrophils appear to infiltrate the injured lung in parallel with 
increased expression of adhesion molecules on endothelial cells and result in elevated local 
chemokines/cytokines  levels  following  hemorrhagic  shock  [29,40,42].  The  intercellular Functional Foods in Health and Disease 2012, 2(10):351-368                                                  Page 353 of 368 
 
adhesion  molecule  (ICAM)-1  enhances  firm  adhesion  of  neutrophils  to  the  vascular 
endothelium  and  is  markedly  up-regulated  after  T-H  [40,43,44].  Furthermore, 
trauma-hemorrhagic  shock  increases  ICAM-1  levels  in  the  lung  [29,40,45].  Chemokines, 
such  as  cytokine-induced  neutrophil  chemoattractant  (CINC)-1  and  CINC-3,  are  potent 
chemoattractants  for  neutrophils.  Moreover,  the  levels  of  the  chemokines,  CINC-1  and 
CINC-3, are elevated in the lung after T-H. Studies have also indicated that overproduction of 
those chemokines leads to lung injury after T-H [29.45]. 
 
Table 1. Protective effects and mechanisms of the resveratrol on different organs following 
trauma-hemorrhage   
 
Species/Targets  Effective 
dose 
Effects and mechanisms  Ref. 
Sprague-Dawley 
rat/Lung 
30 mg/kg of 
body weight 
Reduction of T-H-induced proinflammatory   
parameters (MPO↓,CINC-1↓, CINC-3↓,ICAM-1, and 
IL-6↓) 
[29] 
Sprague-Dawley 
rat/Lung 
30 mg/kg of 
body weight 
HO-1↑(estrogen receptor-dependent) expression  [37] 
Sprague-Dawley 
rat/Liver 
30 mg/kg of 
body weight 
HO-1↑(estrogen receptor-dependent ) expression  [37] 
Sprague-Dawley 
rat/Liver 
30 mg/kg of 
body weight 
Akt-dependent HO-1 expression↑; Proinflammatory   
parameters ↓ (MPO↓,CINC-1↓, CINC-3↓,ICAM-1, and 
IL-6↓) 
[36] 
Sprague-Dawley 
rat/Liver 
30 mg/kg of 
body weight 
ER-related pathway; Proinflammatory    parameters ↓ 
(MPO↓,CINC-1↓, CINC-3↓,ICAM-1, and IL-6↓) 
[28] 
Sprague-Dawley 
rat/Intestine 
30 mg/kg of 
body weight 
P38/HO-1 expression↑ (estrogen receptor-dependent); 
Proinflammatory    parameters ↓(MPO↓,CINC-1↓, 
CINC-3↓,ICAM-1, IL-6↓ and TNF-α↓) 
[22] 
Sprague-Dawley 
rat/Heart 
8 mg/kg of 
body weight 
Reduction of T-H-induced cardiac c-Myc ↑and Pgc-1↑ 
(SIRT1-dependent); Cardiac ATP↓, cytosolic 
cytochrome C↓, TNF-α↓ 
[89] 
Sprague-Dawley 
rat/Heart 
30 mg/kg of 
body weight 
Restores T-H-induced cardiac p-Akt.activity ↑; 
Proinflammatory parameters ↓ (MPO↓,IL-6↓ and 
ICAM-1↓) 
[27] 
Sprague-Dawley 
rat/Endothelium 
30 mg/kg of 
body weight 
Acetylcholine-induced endothelium-dependent 
relaxation↓ (estrogen receptor-dependent); ROS 
radical/NADPH oxidase expression↓ 
[37] 
Sprague-Dawley 
rat/Aorta 
30 mg/kg of 
body weight 
NADPH-stimulated ROS↓; Aortic p22phox, p47phox, 
gp91phox, NOX1 and NOX4 mRNA levels↓ 
[37] 
Wistar 
rat/Arterial 
smooth muscle 
cells 
15 mg/kg of 
body weight 
Inhibit TH-induced mitochondrial membrane potential 
and intracellular ATP decrease 
[100] 
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Furthermore, there is convincing evidence that interleukin (IL)-6 plays a significant role 
on  organ  injuries  and  is  required  for  expression  of  adhesion  molecules  and  release  of 
chemokines [46,47]. IL-6 also appears to be an essential component of the inflammatory 
cascade  that  is  associated  with  lung  injury  in  hemorrhagic  shock  [29,45].  Moreover, 
IL-6-deficient mice shows less neutrophil infiltration and organ damage as compared with 
wild-type mice under those conditions [47,48]. The cytokines are important early mediators 
in  the  lung  during  T-H,  and  are  required  for  expression  of  adhesion  molecules  and 
chemokines  [49,50].  The  ability  of  resveratrol  to  modulate  expression  of  inflammatory 
cytokines as well as adhesion molecules and chemokines suggests a role for resveratrol in the 
regulation of lung inflammation.   
 
The protective effect of resveratrol in the liver following T-H 
The liver is considered to be a critical organ in the development of delayed organ dysfunction 
in  patients  having  traumatic  injuries  and  hemorrhagic  shock  [40,51,52].  T-H  results  in 
excessive production of pro-inflammatory mediators, and the subsequent accumulation of 
neutrophils  in  the  liver  is  associated  with  hepatic  injury  [36,43,52].  Resveratrol  reduces 
neutrophil  and  cytokine  production  in  vivo  in  a  rodent  model  of  LPS-induced  airway 
inflammation [53,54]. Previous studies have shown that resveratrol binds and increases the 
transcriptional activity of estrogen receptor (ER)-α  and ER-β [55]. Previous studies have 
made contributions in exploring the role of sexual dimorphism and response to injury and 
demonstrated the importance of sex steroids on the maintenance of organ function after T-H 
[40,52,56]. Previous studies have also shown that resveratrol binds to ER and activates the 
transcription  of  estrogen-responsive  target  genes  [57].  Our  previous  studies  showed  that 
administration of resveratrol in combination with an ER antagonist ICI 182,780 blocked the 
hepatoprotective effect and demonstrated that ER pathways are critical to the mechanism of 
resveratrol induced post-resuscitation hepatoprotection [28]. Building on these concepts, ER 
pathways may be critical to the use of potential therapies in the treatment of trauma patients 
[28,49]. 
Previous studies have also shown that estrogen administration after T-H up-regulates 
phosphatidylinositol  3-kinase  (PI3K)/protein  kinase  B  (Akt)  expression  via  an  estrogen 
receptor  [58].  The  PI3K/Akt  is  known  to  be  an  endogenous  negative  feedback  or 
compensatory mechanism, which serves to limit pro-inflammatory and chemotactic events in 
response to injury [59,60]. In addition, PI3K/Akt pathway is known to play a pivotal role in 
the ability of neutrophils to undergo chemotaxis [61-63]. Previous studies have shown that 
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induction seems to play a central role in the preservation of organ microcirculation under 
such conditions [64]. A growing body of evidence indicates that Akt activation induces HO-1, 
which is known to play a protective role in many organs under various deleterious conditions, 
including T-H  [64,65].  Up-regulation  of HO-1  causes  a reduction of  cytokines,  adhesion 
molecules, chemokines, and neutrophil accumulation, and ameliorates organ injury in shock 
status  [37,43,45,64].  Studies  have  also  shown  that  administration  of  17β-estradiol  or 
flutamide after T-H increase HO-1 expression, which prevents the organs from dysfunction 
and injury [22,65,66]. Resveratrol-mediated increase in HO-1 is found to be Akt-dependent, 
because co-administration of HO antagonist with resveratrol abolished the increase in HO-1 
and the salutary effects of resveratrol in the liver following T-H [43]. Activation of PI3K/Akt 
signaling cascade by resveratrol  has  been observed in  different  tissues [30,67-69].  These 
results indicate that resveratrol administration after T-H decreases pro-inflammatory mediator 
levels  and  attenuates  liver  damage,  likely  through  Akt-mediated  up-regulation  of  HO-1 
[36,43]. 
 
The protective effect of resveratrol in the intestine following T-H 
Estrogen receptor is also reported to play an important role in intestinal injury after T-H. The 
p38 mitogen activated protein kinase (MAPK) has been reported to regulate inflammatory 
response after T-H [22,70-72]. An increasing body of evidence shows that ERs lead to the 
induction  of  p38  MAPK  [22,70,73].  Estrogen-mediated  attenuation  of  the  inflammatory 
response to shock-induced organ injury is abolished by the presence of a p38 MAPK inhibitor 
SB-203580 [22,70,72]. A growing body of evidence indicates that p38 MAPK activation 
induces  HO-1,  which  is  known  to  play  a  protective  role  in  many  organs  under  various 
deleterious conditions, including T-H [22,70]. Up-regulation of HO-1 causes a reduction of 
pro-inflammatory  mediators,  cytokines/chemokines  and  adhesion  molecules,  along  with 
neutrophil  accumulation  and  amelioration  of  organ  injury  in  shock  status  [41,45,74].  A 
number of studies have shown that p38 MAPK activation contributes to the protection of 
cell/tissue  responses  to  a  variety  of  stimuli  [75-77].  P38  MAPK  phosphorylation  is  also 
reported to be intestine-protective after ischemic preconditioning or T-H [22,70,78]. Studies 
have  also  indicated  that  p38  MAPK  activation  regulates  mucosal  recovery  in 
ischemic-injured  porcine  ileum  [79]  and  protects  glomerular  epithelial  cells  against 
complement-mediated cell injury [80]. It suggests that the salutary effects of resveratrol are 
mediated  by  p38  MAPK-dependent  HO-1  upregulation.  Our  recent  study  showed  that 
treatment  of  animals  with  SB-203580,  which  blocks  p38  MAPK,  abolished 
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salutary effects of resveratrol are mediated in part through ER-dependent p38 MAPK/HO-1 
upregulation. 
 
The protective effect of resveratrol in the heart following T-H 
Resveratrol has been shown to have cardioprotective effects during ischemia reperfusion [81], 
and previous studies have shown that resveratrol can attenuate organ injury after T-H [27,36]. 
Activation of the PI3K pathway protects organs or cells against ischemia-reperfusion injury 
and  hypoxia  through  suppression  of  the  apoptosis  machinery  [82,83].  Inhibition  of  the 
PI3K/Akt pathway with the PI3K inhibitor wortmannin increases serum cytokine levels and 
decreases the survival of mice subjected to sepsis [60,84]. PI3K/Akt pathway is known to 
play a pivotal role in the ability of neutrophils to undergo chemotaxis [64,85]. Studies have 
demonstrated that cardiac injury is associated with increased neutrophil accumulation [40,86] 
and our previous studies have also shown that reduction of neutrophil accumulation after 
hemorrhagic shock in small intestine correlated with the improvement of cardiac function 
[22].  Resveratrol  has  been  shown  to  ameliorate  cardiac  injury  and  production  of 
pro-inflammatory mediators after T-H [27]. Blockade of Akt activation abolishes the salutary 
effects of resveratrol in the heart following T-H [27]. These findings provide evidence that 
resveratrol-mediated cardioprotection is likely mediated via an Akt-dependent pathway after 
T-H [27]. 
Sirt1 (Sirtuin 1) has been shown to regulate mammalian genes transcription and silence 
tumor suppressor genes [87,88]. The Sirt1 transcription-modulating proteins also showed a 
fine balance in response to intracellular cues, such as hypoxia or stress signals. The beneficial 
effects of resveratrol mediated by Sirt1 activation can be contributed by different organs 
[4,89-91]. Studies have shown that resveratrol improves cardiac function following T-H by 
modulating Sirt1 [89]. Resveratrol could abrogate the T-H-induced down-regulation of Sirt1 
expression and most of the effect abolished by sirtinol (a Sirt1 inhibitor). The salutary effect 
of resveratrol on left ventricular contractility and systemic TNF-α levels was abolished by 
sirtinol [89]. 
 
The protective effect of resveratrol on endothelium following T-H 
Previous studies have shown that vascular endothelial cell dysfunction leading to inadequate   
tissue perfusion which occurs after hemorrhagic shock and persists despite fluid resuscitation 
[92,93]. Oxidative stress and superoxide radical generation are believed to contribute to the 
pathogenesis  of  endothelial  dysfunction  in  low-flow  states  [66,93,94].  Endothelial 
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oxygen species (ROS) of the vasculature, and previous studies have shown that there was a 
marked  increase  in  NOX-generated  ROS  by  the  endothelium  under  stressful  conditions 
[66,94]. Elevated ROS is considered a major contributing factor to endothelial dysfunction, 
and anti-oxidants have been found to attenuate ROS-induced injuries [66,94]. Resveratrol has 
been shown to have broad anti-oxidant activities in a number of biological systems [95,96]. 
Resveratrol  has  been  demostrated  to  have  cardioprotective  effects  during 
ischemia-reperfusion through its ROS-scavenging activity [81]. However, the cardiovascular 
benefit of resveratrol may not simply be attributable to its anti-oxidant effect, and recent 
findings  indicate  that  resveratrol  reduces  NOX  activity  in  rat  aortic  homogenate  and 
macrophages [97]. The NOX complex in phagocytic cells is a flavocytochrome composed of 
two membrane bound proteins, gp91phox and p22phox, and a cytosolic protein, p47phox 
[98]. Our recent studies have shown that resveratrol prevents T-H-elicited oxidative stress 
and protects endothelium from subsequent functional damages [94]. The beneficial effects 
include suppression of the NOX activity and direct scavenging of ROS. The inhibitory effect 
of resveratrol on the NOX activity appears to be mediated through influence of the active 
NOX enzyme complex assembly in the cell membrane and the cytosol, as is evidenced from 
reduced membrane-bound proteins p22phox and gp91phox and cytosolic protein p47phox 
[37,94]. Furthermore, the recent study has shown that resveratrol could reduce mitochondrial 
dysfunction  and  lysosomal  stability  of  rat’s  arteriolar  smooth  muscle  cells  (ASMCs) 
following T-H [99]. 
HO-1  appears  to  act  as  a  protective  agent  in  many  organs  against  insults,  such  as 
ischemia  and  oxidative  stress  [65,100].  Resveratrol  can  modulate  HO-1  induction  and 
previous studies also have shown that estrogen or flutamide enhances HO-1 expression via 
ER  [22,36].  Our  recent  studies  suggest  that  up-regulation  in  HO-1  was  associated  with 
prevention of endothelial dysfunction and the salutary effects of resveratrol on endothelial 
function are mediated in part by up-regulation of the HO-1- related pathway via ER [94]. 
 
CONCLUSIONS: 
Resveratrol has been shown to have the beneficial effects in various studies and experimental 
conditions.  There  is  increasing  evidence  that  resveratrol  maintains  organ  function  after 
trauma or shock-like states. Resveratrol can attenuate organs injury following T-H through 
multiple  pathways.  However,  the  protective  benefits  of  resveratrol  may  not  simply  be 
attributed to its anti-inflammatory or anti-oxidant effect. It is implicated that resveratrol is 
also mediated in part via a variety of intracellular signaling pathways including the regulation 
of  the  HO-1/MAPK,  PI3K/Akt,  ER,  and  Sirt1  (Figure  1).  This  complex  network  needs Functional Foods in Health and Disease 2012, 2(10):351-368                                                  Page 358 of 368 
 
additional elucidation in future experimental studies and clinical trials. 
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Figure  1.  The  pathways  of  resveratrol  on  maintenance  of  organ  function  following 
trauma-hemorrhage. ER, estrogen receptor; SIRT1, sirtuin 1; HO-1, hemeoxygenase 1; ROS, 
reactive oxygen species; ICAM, intercellular adhesion molecule; NOX, NADPH oxidase. 
 
Abbreviations:  Trauma-Hemorrhage  (T-H),  Estrogen  Receptor  (ER),  Reactive  Oxygen 
Species  (ROS),  Hemeoxygenase-1  (HO-1),  Nuclear  factor-E2-  related  factor-2  (Nfr2), 
Nuclear Factor-Kappa B (NF-kB), Phosphatidylinositol 3-kinase (PI3K), Protein Kinase B 
(Akt), Mitogen-Activated  Protein  Kinase (MAPK), Cyclooxygenase-1 (COX-1),  Sirtuin 1 
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